Matrix metalloproteinase 9 may represent a key modulator of the biological pathogenic mechanisms triggered in the periodontium by the binomial CP-RA, the levels of this marker being therefore important, for the identification of patients affected by this association. This evidence concerns the gene MMP9 and rheumatoid arthritis.